Xilio Therapeutics, Inc. (32) | Uncategorized (7)
Recent Contracts
-
Offer Letter, dated March 15, 2023, by and between Xilio Therapeutics, Inc. and Kevin Brennan
(Filed With SEC on April 3, 2023)
-
Letter Agreement, dated September 30, 2021, by and between the Registrant and Salvatore Giovine
(Filed With SEC on March 1, 2022)
-
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended
(Filed With SEC on March 1, 2022)
-
Letter Agreement, dated September 30, 2021, by and between the Registrant and Martin Huber
(Filed With SEC on October 1, 2021)
-
Letter Agreement, dated May 24, 2019, by and between the Registrant and Joseph Farmer
(Filed With SEC on October 1, 2021)
-
Letter Agreement, dated September 30, 2021, by and between the Registrant and Ren Russo
(Filed With SEC on October 1, 2021)
-
Cross-License Agreement, dated as of December 16, 2020, by and between the Registrant and AskGene Pharma, Inc
(Filed With SEC on October 1, 2021)
